GNRH1 and adenomyosis: In this study, long-term pre-treatment with the GnRH agonist significantly improved the implantation rate, clinical pregnancy rate, and on-going pregnancy rate of patients with adenomyosis in frozen embryo transfer (FET) cycles (8).